Menu
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Clinical Trial
Investor Centre
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
Communication
In the News
Presentations
Contact Us
Contact Us
Email Alerts
In the news
Recent Posts
Interim Data from ACCENT Pancreatic Cancer Trial
Dr Chris Burns elected as a Fellow to the Australian Academy of Health and Medical Sciences (AAHMS)
ASX Briefs podcast | Interview with Dr Chris Burns
Recruitment Restarts in Accent Pancreatic Cancer TrialÂ
NBN News Interview
Dr Chris Burns Announced as Co-Recipient of 2024 Prime Minister's Prize for Innovation
Categories
Archive
Company News
Investor Newsletters
Videos
25 Jul 2024
Three confirmed partial responses observed in Phase 2a ACCENT trial
Read More
11 Jul 2024
JustStocks Feature Article and Video Interview with Amplia CEO Dr Chris Burns
Read More
03 Jul 2024
Recruitment of first 26 patients of Phase 2A ACCENT Trial now complete
Read More
1
